Steven Anderson
About Steven Anderson
Steven Anderson is an Associate Director of Toxicology at Supernus Pharmaceuticals, Inc., with a Doctor of Philosophy in Comparative Biomedical Sciences from North Carolina State University. He has extensive experience in toxicology, regulatory compliance, and ecotoxicology, having held various roles in prominent companies and contributed to significant regulatory submissions.
Work at Supernus Pharmaceuticals
Steven Anderson currently serves as the Associate Director of Toxicology at Supernus Pharmaceuticals, Inc. He has held this position since 2024, contributing to the company's toxicology research and regulatory compliance efforts. His role involves overseeing toxicology studies and ensuring that they meet regulatory standards. Anderson's expertise in toxicology enhances the company's ability to develop safe and effective pharmaceutical products.
Education and Expertise
Steven Anderson has a solid educational foundation in veterinary medicine and biomedical sciences. He earned his Doctor of Veterinary Medicine (DVM) from Oklahoma State University, studying from 1988 to 1992. He also obtained a Doctor of Philosophy (PhD) in Comparative Biomedical Sciences with a focus on Genetics and Molecular Biology from North Carolina State University, where he studied from 1996 to 2001. Additionally, he holds a Bachelor of Science (BS) in Zoology from the University of Oklahoma, completed between 1980 and 1985.
Background
Steven Anderson has extensive experience in the field of toxicology, having worked in various roles across multiple organizations. He began his career as a Postdoctoral Fellow at GSK, focusing on Investigative Pathology and Toxicology from 2000 to 2003. He then held positions at Bayer, PPD, Albemarle Corporation, and Merial, where he developed expertise in regulatory compliance and toxicology study design. His diverse background includes work as a Study Director/Pathologist at Bridge Laboratories and as a Consultant for the FDA.
Achievements
Throughout his career, Steven Anderson has demonstrated a strong capability in regulatory submissions and compliance. He has been involved in FDA New Drug Application (NDA) and Investigational New Animal Drug (INAD) submissions, showcasing his expertise in navigating regulatory processes. His experience includes developing regulatory strategies that align with corporate objectives and performing risk analyses for pharmaceutical and chemical products. Anderson is recognized for his ability to collaborate effectively across functions within the industry.
Professional Experience
Steven Anderson has held various significant positions in the toxicology field. He worked as a Principal Scientist at Bayer from 2003 to 2006 and served as Associate Director at PPD from 2006 to 2007. His tenure at Albemarle Corporation as Toxicology Advisor II lasted from 2013 to 2022. In addition, he briefly consulted for the FDA in 2022. His roles have equipped him with a broad understanding of ecotoxicology and environmental fate studies, as well as the use of computational tools in toxicology research.